PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 327.00
Bid: 327.00
Ask: 330.00
Change: 9.00 (2.83%)
Spread: 3.00 (0.917%)
Open: 318.00
High: 327.00
Low: 318.00
Prev. Close: 318.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jan 2021 07:00

RNS Number : 0825M
Aptitude Software Group PLC
19 January 2021
 

 

19 January 2021

 

Aptitude Software Group plc

("Aptitude Software" or the "Group")

Trading Update

 

Aptitude Software, a specialist provider of powerful financial management software to large global businesses, today provides an update for the year ended 31 December 2020 and the current financial year.

Trading Update

Aptitude Software has traded in line with the Board's expectations in 2020. A strong final quarter's new business performance in several of the Group's key markets provides the business with greater revenue visibility for 2021.

Annual Recurring Revenue ('ARR') grew by 11% on a constant currency basis in the year to £31.2 million (31 December 2019: £28.1 million, 30 June 2020: £29.3 million - both restated for the prevailing exchange rates at 31 December 2020), driven by both new customer wins and the expansion of existing customer relationships. The Group's balance sheet remains strong with no bank loans and benefitting from cash as at 31 December 2020 of £44.8 million (31 December 2019: £33.0 million).

In the final quarter of the year the Group made good progress, particularly in the North American technology and insurance sectors:

· Following the launch of Aptitude Accounting Hub and Aptitude Insurance Calculation Engine as Software-as-a-Service ('SaaS') at this year's AptConnect user and partner conference, the Group entered into multi-year SaaS agreements with two North American insurers; and

· Building on the technology sector sales announced earlier in the year, the Group completed a new business SaaS agreement with a leading global medical technology company for the use of the Aptitude Revenue Management and Aptitude Lease Accounting Engine products. This success further demonstrates the value realisable by clients of using more than one of the Group's tightly integrated and complementary applications.

These and other new business successes have been complemented by the expansion of the use of our applications in several of our existing clients including one of the largest North American telecommunications companies and a European financial services organisation.

In a year in which some of our clients and prospects have re-prioritised their investment decisions in the short term as a result of the pandemic, the Board is pleased with the overall performance of the Group and is encouraged by the strong sales performance in the final quarter.

Outlook

Aptitude Software enters the current financial year with improved revenue visibility due to the sales successes achieved in the final quarter of 2020. These successes have strengthened the demand for implementation services from Aptitude Software and its partner network. Whilst an increasing proportion of implementations will continue to be led by partners, contributing to a year-on-year reduction in services performed directly by Aptitude Software in 2021, services revenue for the coming year is now anticipated to be slightly ahead of earlier expectations.

Excellent progress has also been achieved in 2020 on a series of strategic initiatives to provide the Group with growth opportunities for 2021 and beyond. These initiatives include:

· Continued development of the partner network with a number of joint propositions established in the year; and

· The launch of Aptitude Accounting Hub and Aptitude Insurance Calculation Engine as SaaS-offerings, ensuring we can capitalise on the accelerated move to cloud experienced in 2020. With the addition of these two strategic products to the Group's growing SaaS suite, most new clients are expected to deploy the Group's software via the SaaS model.

Overall, the Group looks forward to the year ahead with confidence and now anticipates a 2021 financial performance above current market expectations and at least consistent with that expected in 2020.

 

Contacts

Philip Wood, Deputy Chief Executive Officer and Chief Financial Officer 020-3687-3200

Caroline Forde / Sam Modlin, Alma PR 020-3405-0205

aptitude@almapr.co.uk

 

1 Annual Recurring Revenue ("ARR") is the value of Aptitude Software's software and subscription recurring revenue at a specific point in time, normalised to a one-year period. ARR includes recurring revenues contracted but yet to commence and excludes recurring revenues which are currently being received but are known to be terminating in the future.

About Aptitude Software

Aptitude Software's innovative solutions address the growing trend for digital finance transformation complemented by regulatory-focused applications. Our various products take data from complex systems, typically with multiple siloed data sources across multiple business entities, to create a unified view of finance. This allows our clients to reap significant benefits including business insights, enhanced control and regulatory compliance.

Our clients include some of the world's largest companies, typically organisations with complex financial data and technology landscapes. Development, together with a growing number of other services, continues to be performed at the Aptitude Innovation Centre in Poland with sales, support and implementation services provided from Aptitude Software's London headquarters and the North American and Singaporean regional businesses.

Aptitude Software has six office locations around the world, with clients across four continents.

www.aptitudesoftware.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWSNRAWUAAAR
Date   Source Headline
18th Mar 201511:23 amRNSResults of General Meeting
6th Mar 201512:22 pmRNSHolding(s) in Company
26th Feb 20153:39 pmRNSHolding(s) in Company
25th Feb 20152:26 pmRNS2014 Final Dividend
25th Feb 20157:02 amRNSReturn of Value
25th Feb 20157:01 amRNSPreliminary Results
28th Jan 20152:02 pmRNSHolding(s) in Company
23rd Jan 20151:17 pmRNSHolding(s) in Company
23rd Jan 20157:00 amRNSTrading Update
21st Jan 201512:14 pmRNSDirector Declaration
5th Jan 20157:00 amRNSBlocklisting Interim Review
5th Dec 20147:00 amRNSAcquisition
3rd Nov 20147:00 amRNSTotal Voting Rights
30th Oct 20147:00 amRNSInterim Management Statement
7th Oct 20142:28 pmRNSAdditional Listing
30th Sep 20142:47 pmRNSBlocklisting Interim Review
15th Sep 20145:04 pmRNSHolding(s) in Company
1st Sep 20147:00 amRNSTotal Voting Rights
21st Jul 20147:00 amRNSInterim Results
14th Jul 20143:00 pmRNSNotice of Results
1st Jul 201412:11 pmRNSBlocklisting Interim Review
20th Jun 20148:10 amRNSDirector Declaration
17th Jun 20147:00 amRNSStatement regarding Elektron Technology plc
11th Jun 20149:34 amPRNForm 8 (OPD) Microgen plc
5th Jun 20142:20 pmRNSForm 8.3 - Microgen Plc
5th Jun 201412:13 pmRNSForm 8.3 - Microgen PLC
2nd Jun 20145:33 pmRNSForm 8 (OPD) Microgen plc
2nd Jun 201412:35 pmRNSForm 8.3 - [Microgen Plc]
2nd Jun 201410:50 amRNSTotal Voting Rights
30th May 201410:23 amBUSForm 8.3 - Microgen Plc
29th May 201410:08 amRNSRule 8.3 opening position disclosure
27th May 20142:39 pmPRNForm 8.3 - Microgen plc
27th May 20142:10 pmRNSStatement re Elektron Technology Plc
27th May 201411:44 amRNSForm 8.3 - Microgen Plc
23rd May 20145:22 pmRNSForm 8.3 - Microgen plc
23rd May 201410:22 amRNSForm 8.3 - Microgen Plc
21st May 20143:29 pmRNSForm 8.3 - [Microgen plc]
21st May 20143:04 pmRNSForm 8.3 - Microgen Plc
21st May 20142:13 pmRNSForm 8.3 - MICROGEN PLC
21st May 20141:10 pmRNSForm 8.3 - Microgen Plc
21st May 201411:48 amBUSForm 8.3 - Microgen Plc
21st May 201411:46 amRNSForm 8.3 - [MICROGEN PLC]
21st May 201411:21 amRNSForm 8.3 - MICROGEN ORD GBP0.05
21st May 20149:00 amRNSResponse to Microgen
20th May 201412:39 pmRNSFurther Statement Re Elektron Technology Plc
20th May 201410:20 amRNSStatement re Elektron Technology
2nd May 201410:48 amRNSDirector/PDMR Shareholding
1st May 201410:28 amRNSTotal Voting Rights
28th Apr 201411:28 amRNSResult of AGM
28th Apr 20147:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.